Following a 7-month trial on the use of Entonox ® for the relief of pain or anxiety during intrauterine device (IUD) or intrauterine system (IUS) fitting, we now offer this method of pain relief to all women attending for an intrauterine procedure. It is available to any patient who wishes to use it but its use is entirely optional. Entonox can be used alongside other analgesics and there is no need for the woman to decide beforehand.
Our services currently insert a minimum of 20 IUDs/IUSs per week at two clinic sites in Central Buckinghamshire, UK. The clinics serve all ages and client groups who mainly self-refer, as well as accepting general practitioner (GP) referrals for emergency IUDs.
Reducing pain and anxiety for these procedures has been much debated over the last few years. Hutt 1 and more recently Akintomide et al. 2 have advocated an increased use of intracervical local anaesthesia. Hutt 3 suggests that lignocaine gel is ineffective and that "…it is simply a salve to our guilty consciences".
Entonox provides pain relief and conscious sedation for a variety of short-term procedures 4 and is licensed for such indications. 5 The manufacturer of Entonox, BOC, expects that within a minute of discontinuing breathing Entonox the effect has worn off so clients could drive within 30 minutes of the procedure. This is confirmed in the Summary of Product Characteristics (SPC). 5 Our National Health Service Trust states that clients should not drive for 12 hours after using Entonox. We counsel women prior to procedures and are hoping that the Trust will take a more pragmatic stance in the future in the light of BOC's guidance and the information within the SPC. Our current information states: "[Entonox] wears off within a minute or two of stopping breathing it, however, please note that: (a) it is currently a Trust policy that she should not drive herself home if she has used Entonox so needs to arrange a lift, and (b) she should not use Entonox if she has recently had a 'burst eardrum' or within 48 hours of SCUBA diving".
Since introducing Entonox in our clinics, we have had a steady rise in the number of clients opting for IUD/IUS. Some state that they choose our service "… because you have the 'gas and air'". However, some women also state that at a previous procedure carried by their GP they had not been advised to take any analgesics beforehand nor were they offered any at the procedure. The clinics run a large teaching practice for both GPs and nurses, and the many GPs we talk to who state that they never give intracervical local anaesthesia as "women don't need it" are perhaps unaware of the number of women who choose to go to a Level 3 service for their next IUD/IUS in the hope of a better experience when analgesia is available. I suggest that these women are reluctant to tell their GPs, whom they like and trust, that the procedure was less than perfect.
Striking the balance between letting women know that Entonox is available and worrying some who say "…if it is so painful you need 'gas and air' I am not having one", has been something we have addressed in our literature and by having a poster containing information and comments in the waiting room.
The final word needs to go to one of our satisfied clients: "10 years of contraception and gas to breathe when it's fitted, what's not to like?".
Journal readers who would like further information on using Entonox for procedures or who are interested in the questionnaire from which the quotations above were taken and its audit may e-mail me direct.
Comment on 'Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives' I fully endorse reducing anxiety, 'verbal anaesthesia', the skill of the health care provider (HCP) and having a 'chatty' assistant present: these are essential but not always sufficient.
As the Bahamondes et al. 1 review states, around 17% of nulliparous and 11% of parous women report pain that is 'severe'. If given freedom to say so, a further group of women reports pretty nasty discomfort. In our own study 2 38% of subjects reported their insertion pain as very or moderately distressing, whereas their doctor reported it as 'mild' or 'minimal'! Picture the scene, repeated intermittently anywhere that intrauterine contraceptives (IUCs) are inserted. The client is relaxed, appears an ideal candidate, the right ambience and skills are all there. Yet, the moment holding forceps are applied (whatever the design, it is a myth that Judd-Allis tenaculums are especially benign), she yelps with pain. Importantly, for this minority of women, this sharp somatic pain seems then to worsen the whole experience including later (cramping) pains.
The authors quoting a Cochrane Review 3 say that "pharmacological strategies" fail to show "clear evidence that pain is significantly reduced during or after routine IUC placement". Yet two double-blind randomised studies 2 4 were not evaluated, totalling 190 women. With tolfenamic acid 200 mg three times a day started post-insertion, significantly reduced ( p<0.01) spasmodic pain was reported in the subsequent 24 hours 4 ; and measured by visual analogue scales (VAS), there was significant post-insertion pain reduction at 10 minutes with mefenamic acid 500 mg given 60 minutes preinsertion. 2 Moreover, the "absence of proof " from other good studies cited in the Cochrane Review 3 cannot be "proof of absence" of benefit by non-steroidal anti-inflammatory drugs (NSAIDS) for prostaglandin-related pain.
For the unpredictably severe tenaculum pain, the problem is wide individual variation; and neither study 2 4 demonstrated benefit by NSAIDs. What about local anaesthesia? This has indeed only been evaluated for other gynaecological procedures. But so what, if that welldefined pain is produced identically? Robinson et al. 5 reported in a doubleblind randomised controlled trial that hysterosalpingography subjects receiving a 1% lidocaine cervical block totalling 6 ml had significantly less pain ( p<0.001) measured by VAS from tenaculum placement, compared with a placebo intracervical saline injection group and a no-injection group. Another single-blind study, admittedly too recent for Bahamondes et al. to cite, randomised 74 women. Those receiving 2 ml 1% lidocaine at the 12 o'clock position had lower mean pain levels by VAS at tenaculum placement ( p<0.001) than the controls receiving 2% lidocaine gel topically. 6 Anaesthetists maintain it is more effective to pre-empt most pains than to try to remove them when present, and lower total analgesic doses are required. My teaching pending more databased on available literature, clinical experience and a desire to give the woman the benefit of the doubt about how much pain she will haveis that premedication with an NSAID of the HCP's choice about 40 minutes beforehand should be routinely offered to everyone: unless rejected or contraindicated. Everyone should also be offered a 1 ml dose of plain lidocaine 1% or prilocaine 4%, injected at 12 o'clock slowly through the finest available needle, 1-2 minutes ahead of the tenaculum. This reliably prevents the tenaculum causing pain. Women are of course welcome to reject this offer too, but one group never does so: those women who have previously experienced severe tenaculum pain, who also find the 1 ml injection negligibly painful in comparison. (NB. Full cervical anaesthesia is quite different, reserved for the cases described in the Bahamondes et al. review.)
Finally, to minimise pain at IUC insertion there is a much-overlooked opportunity with many other advantages, namely just after surgical termination of pregnancy: given the already-present local or general anaesthesia. Misgivings about expulsion rates and infections are without foundation. 7 This should be the norm, with of course full counselling well beforehand and, again, easy opt-out.
Comment on 'Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives'
Congratulations are due to the authors for producing much-needed guidelines. 1 These are necessarily a consensus owing to the lack of quality studies on pharmacological interventions. Since 2009 I have provided a referral service for intrauterine device (IUD) problems, and currently manage 400-500
referrals per year for failed insertion or removal, or a history of severe pain and/or vasovagal syncope (VVS). Women referred are motivated to persevere with this method despite a bad experience. There are no data to indicate how many women are put off by a poor experience and rule out this method of contraception and/or menstrual control. In my experience, concerns around the fitting are the main barrier to improving the overall low uptake of intrauterine methods in the UK. I would strongly echo the consensus that the setting, confidence and technique of the provider, and particularly the presence of an assistant skilled at addressing anxiety, are key to the overall experience. There are six points where I differ from Bahamondes et al.'s recommended practice. 1 I am fortunate to have an electric lithotomy couch but rarely use the leg supports, usually only where access to the cervix is particularly difficult. My preferred position is sitting on a stool with wheels at the side of the couch rather than with the woman at the end of the couch. Importantly the bed is elevated enough that my legs fit in under the couch so the cervix is comfortably at eye level. 2 The consensus view was that a tenaculum should always be applied. I avoid this painful stimulus if fitting is possible using gel alone. A tenaculum is essential for GyneFix ® . However, with framed devices it is often unnecessary and will only increase pain. Admittedly I have the benefit of a scanner at the bedside and routinely check the position of any IUD. Accurate fundal placement and minimising the risk of perforation depend on good technique but this need not include use of a tenaculum in many cases. 3 I disagree with the authors' recommended toothed tenaculum pictured in their Figure 1 . Although rarely reported, 2 I have seen several cases with an IUD thread exiting the cervix through a fistula, and one case where an intrauterine system reservoir was visibly protruding from a fistula with the thread running back into the fistula and out
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